EMA-2023-0082-V282

Type II variation for application EMA-2023-0082. Type II variation: Specification Change for Respiralimab — minor update

Variation Number
EMA-2023-0082-V282
Type
Type II
Application
EMA-2023-0082
Change
CHG-2023-0282
Status
Blocked
Fee
€22,349
Submitted
—
Approved
—
Description

Type II variation: Specification Change for Respiralimab — minor update